Literature DB >> 31098707

Improved blood pressure and left ventricular remodelling in children on chronic intermittent haemodialysis: a longitudinal study.

Nabil Melhem1, Alex Savis2, Arran Wheatley1, Helen Copeman1, Kay Willmott1, Christopher J D Reid1, John Simpson2, Manish D Sinha3,4.   

Abstract

OBJECTIVES: We aimed to examine longitudinal changes in left ventricular (LV) structure and function and evaluate factors associated with LV remodelling in children on chronic haemodialysis.
METHODS: Retrospective longitudinal study including all children from the start of chronic haemodialysis with two or more m-mode 2D echocardiograms and tissue Doppler studies. Left ventricular mass (LVM) in g/m2.7, geometry and LV function were compared at baseline (dialysis start) with follow-up studies at least 6 months following commencement. Left ventricular hypertrophy (LVH) was defined if greater than 95th percentile as per age-specific centiles. We also defined LVH as indexed LV mass index (LVMI) > 51 g/m2.7 and using LV mass-for-height z-scores greater than the 95th percentile. Biochemical data, interdialytic weight change and blood pressure level were assessed for their association with change in indexed LVM.
RESULTS: Twenty-three of the 32 children < 18 years were included (n = 5, < 5 years) with last follow-up study performed following dialysis after a median (IQR) of 21 (10-34) months. The prevalence of LVH reduced significantly (69.6%, (n = 16/23) vs. 39.1% (n = 9/23), P = 0.002); LV geometry improved (13% concentric and 56.5% eccentric vs. 8.7% and 17.4% respectively) with mean ± SD reduction in indexed LVM (50.8 ± 23.1 g/m2.7 vs. 38.6 ± 14.7 g/m2.7, P = 0.002) and LV mass-for-height z-scores (0.67 ± 1.66 vs. - 0.46 ± 1.88, P = 0.002) from baseline to last follow-up respectively. There was no change in systolic function (LV fractional shortening, 37% vs. 38%, P = 0.39) and diastolic function (mean E/E' 10.8 vs. 9.0, P = 0.09). Multiple regression analysis identified improved systolic BP control (β = 0.41, P = 0.04) as an independent predictor for change in indexed LVM.
CONCLUSIONS: LV structure and function can improve in children despite long-term chronic intermittent haemodialysis. Cardiovascular health in this population does not always deteriorate but can be stabilised and indeed improved with optimal blood pressure management.

Entities:  

Keywords:  Cardiac; Dialysis; ESKD; Renal replacement therapy

Mesh:

Year:  2019        PMID: 31098707     DOI: 10.1007/s00467-019-04272-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrology Consortium study.

Authors:  Mark M Mitsnefes; Gina M Barletta; Ian G Dresner; Deepa H Chand; Denis Geary; Jen-Jar Lin; Hiren Patel
Journal:  Pediatr Nephrol       Date:  2006-06-29       Impact factor: 3.714

Review 3.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

4.  Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study.

Authors:  Jaap W Groothoff; Mariken P Gruppen; Martin Offringa; Jeroen Hutten; Marc R Lilien; Nicole J Van De Kar; Eric D Wolff; Jean Claude Davin; Hugo S A Heymans
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

5.  Reduced systolic myocardial function in children with chronic renal insufficiency.

Authors:  Marcello Chinali; Giovanni de Simone; Maria Chiara Matteucci; Stefano Picca; Antonio Mastrostefano; Ali Anarat; Salim Caliskan; Nikola Jeck; Thomas J Neuhaus; Amira Peco-Antic; Licia Peruzzi; Sara Testa; Otto Mehls; Elke Wühl; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2007-01-10       Impact factor: 10.121

6.  Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.

Authors:  Wacharee Seeherunvong; Carolyn L Abitbol; Jayanthi Chandar; Paolo Rusconi; Gaston E Zilleruelo; Michael Freundlich
Journal:  Pediatr Nephrol       Date:  2012-06-19       Impact factor: 3.714

7.  When does the cardiovascular disease appear in patients with chronic kidney disease?

Authors:  Betul Sozeri; Sevgi Mir; Orhan Deniz Kara; Erturk Levent
Journal:  Pediatr Cardiol       Date:  2010-04-17       Impact factor: 1.655

8.  Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure.

Authors:  Jun Oh; Rainer Wunsch; Martin Turzer; Malte Bahner; Paolo Raggi; Uwe Querfeld; Otto Mehls; Franz Schaefer
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

9.  Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report.

Authors:  Sevcan A Bakkaloglu; Arda Saygili; Lale Sever; Aytul Noyan; Sema Akman; Mesiha Ekim; Nejat Aksu; Beyza Doganay; Nurdan Yildiz; Ali Duzova; Alper Soylu; Harika Alpay; Ferah Sonmez; Mahmut Civilibal; Sevcan Erdem; Firat Kardelen
Journal:  Nephrol Dial Transplant       Date:  2009-06-18       Impact factor: 5.992

10.  Left ventricular dysfunction in the haemodialysis population.

Authors:  Manish M Sood; Robert P Pauly; Claudio Rigatto; Paul Komenda
Journal:  NDT Plus       Date:  2008-08
View more
  1 in total

Review 1.  Echocardiogram screening in pediatric dialysis and transplantation.

Authors:  Amelia K Le Page; Naganandini Nagasundaram; Ari E Horton; Lilian M Johnstone
Journal:  Pediatr Nephrol       Date:  2022-09-17       Impact factor: 3.651

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.